CRS: BJMC
Position: Community Coordinator
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
